JP2019514417A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514417A5
JP2019514417A5 JP2018559814A JP2018559814A JP2019514417A5 JP 2019514417 A5 JP2019514417 A5 JP 2019514417A5 JP 2018559814 A JP2018559814 A JP 2018559814A JP 2018559814 A JP2018559814 A JP 2018559814A JP 2019514417 A5 JP2019514417 A5 JP 2019514417A5
Authority
JP
Japan
Prior art keywords
mutgs
nucleic acid
expression system
vector
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018559814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514417A (ja
JP6972022B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/032139 external-priority patent/WO2017197098A1/en
Publication of JP2019514417A publication Critical patent/JP2019514417A/ja
Publication of JP2019514417A5 publication Critical patent/JP2019514417A5/ja
Priority to JP2021178542A priority Critical patent/JP7344949B2/ja
Application granted granted Critical
Publication of JP6972022B2 publication Critical patent/JP6972022B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018559814A 2016-05-11 2017-05-11 グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択 Active JP6972022B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021178542A JP7344949B2 (ja) 2016-05-11 2021-11-01 グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662334966P 2016-05-11 2016-05-11
US62/334,966 2016-05-11
PCT/US2017/032139 WO2017197098A1 (en) 2016-05-11 2017-05-11 Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021178542A Division JP7344949B2 (ja) 2016-05-11 2021-11-01 グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択

Publications (3)

Publication Number Publication Date
JP2019514417A JP2019514417A (ja) 2019-06-06
JP2019514417A5 true JP2019514417A5 (enExample) 2020-06-18
JP6972022B2 JP6972022B2 (ja) 2021-11-24

Family

ID=58873869

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018559814A Active JP6972022B2 (ja) 2016-05-11 2017-05-11 グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択
JP2021178542A Active JP7344949B2 (ja) 2016-05-11 2021-11-01 グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021178542A Active JP7344949B2 (ja) 2016-05-11 2021-11-01 グルタミンシンセターゼ遺伝子内相補ベクターを用いた高レベルのヘテロマータンパク質発現細胞の直接選択

Country Status (17)

Country Link
US (2) US11384140B2 (enExample)
EP (2) EP3455359B1 (enExample)
JP (2) JP6972022B2 (enExample)
KR (2) KR102323519B1 (enExample)
CN (2) CN115873904A (enExample)
AU (2) AU2017263454B2 (enExample)
BR (1) BR112018073316A2 (enExample)
CA (1) CA3024027A1 (enExample)
CL (1) CL2018003210A1 (enExample)
EA (1) EA201892588A1 (enExample)
ES (1) ES2914118T3 (enExample)
IL (2) IL300591A (enExample)
MA (1) MA44976A (enExample)
MX (2) MX394682B (enExample)
SG (1) SG11201810040WA (enExample)
TW (2) TWI757291B (enExample)
WO (1) WO2017197098A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018093331A1 (en) * 2016-11-16 2018-05-24 Agency For Science, Technology And Research Attenuated glutamine synthetase as a selection marker
BR112019024750A2 (pt) 2017-05-24 2020-06-09 Thoeris Gmbh uso de glutamina sintetase no tratamento da hiperamonemia
CN109988777A (zh) * 2017-12-29 2019-07-09 南京金斯瑞生物科技有限公司 谷氨酰胺合成酶基因以及应用
SG11202109642SA (en) * 2019-05-07 2021-10-28 Amgen Inc Vectors and expression systems for producing recombinant proteins
WO2023011442A1 (en) * 2021-08-03 2023-02-09 Shanghai Zhenge Biotechnology Co., Ltd. Selectable markers for eukaryotic expression system
CN118804978A (zh) * 2021-12-27 2024-10-18 上海臻格生物技术有限公司 用于重组生产系统的新型标志物
EP4496884A1 (en) * 2022-03-23 2025-01-29 Boehringer Ingelheim International Gmbh New glutamine synthetase variants as selection marker
AU2023238775A1 (en) 2022-03-23 2024-10-31 Boehringer Ingelheim International Gmbh Bacterial glutamine synthetase as selection marker in mammalian cells
WO2025037708A1 (en) * 2023-08-16 2025-02-20 Korea Advanced Institute Of Science And Technology Method for selection of cell line expressing high levels of recombinant protein using glutamine synthetase split expression vector
WO2025128343A1 (en) 2023-12-11 2025-06-19 Just-Evotec Biologics, Inc. Protein expression using trans-splicing and split selectable markers
CN118006685B (zh) * 2024-04-07 2024-07-23 上海碧博生物医药科技有限公司 一种快速的高表达单克隆细胞株构建方法
WO2025250814A1 (en) * 2024-05-31 2025-12-04 Amgen Inc. Intein based split glutamine synthetase engineering

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
JPH0819508B2 (ja) 1987-08-19 1996-02-28 三菱マテリアル株式会社 Fe−Co基合金製高周波用磁芯材
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
US5624818A (en) 1991-09-09 1997-04-29 Fred Hutchinson Cancer Research Center Nucleic acids encoding regulatory proteins that dimerize with Mad or Max
CA2121798C (en) 1991-10-25 2007-07-24 Richard J. Armitage Novel cytokine
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化b−b10
US5573925A (en) 1994-11-28 1996-11-12 The Wistar Institute Of Anatomy And Biology P53 proteins with altered tetramerization domains
CA2222914C (en) 1995-06-07 2002-04-02 Immunex Corporation Novel cd40l mutein
US5916771A (en) 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
US6342345B1 (en) 1997-04-02 2002-01-29 The Board Of Trustees Of The Leland Stanford Junior University Detection of molecular interactions by reporter subunit complementation
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
DK1196566T3 (da) * 1999-07-12 2006-06-06 Genentech Inc Ekspressionsvektorer og -metoder
GB9928787D0 (en) 1999-12-03 2000-02-02 Medical Res Council Direct screening method
GB0025144D0 (en) 2000-10-13 2000-11-29 Medical Res Council Concatenated nucleic acid sequences
PT1434871T (pt) * 2001-09-20 2017-04-05 Immunex Corp Seleção de células que expressam polipéptidos heteroméricos
GB0200977D0 (en) * 2002-01-17 2002-03-06 Lonza Biologics Plc Glutamine-auxotrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium
WO2004038003A2 (en) * 2002-10-25 2004-05-06 Five Prime Therapeutics, Inc. Human polypeptides encoded by polynucleotides and methods of their use
US7384744B2 (en) * 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
US20040202995A1 (en) 2003-04-09 2004-10-14 Domantis Nucleic acids, proteins, and screening methods
US7674618B2 (en) * 2003-09-04 2010-03-09 Medarex, Inc. Expression vector
WO2006036834A2 (en) 2004-09-24 2006-04-06 Amgen Inc. MODIFIED Fc MOLECULES
US8053238B2 (en) 2005-10-31 2011-11-08 Unhwa Corporation Isolated population of plant single cells and method of preparing the same
US20070254338A1 (en) * 2006-04-24 2007-11-01 Amgen Inc. Method for making recombinant protein using complementation dependent DHFR mutants
WO2008154014A2 (en) 2007-06-11 2008-12-18 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
WO2012027533A1 (en) * 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
US20130244231A1 (en) * 2010-11-08 2013-09-19 Jcr Pharmaceuticals Co., Ltd. Novel expression vector
WO2012095514A1 (en) * 2011-01-14 2012-07-19 Vivalis Recombinant protein production system
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
AU2012203048A1 (en) * 2011-05-24 2012-12-13 Agency For Science, Technology And Research IRES mediated multicistronic vectors
KR101411740B1 (ko) * 2012-05-29 2014-06-27 한화케미칼 주식회사 항체 발현용 바이시스트로닉 발현벡터 및 이를 이용한 항체의 생산 방법

Similar Documents

Publication Publication Date Title
JP2019514417A5 (enExample)
JP2011504721A5 (enExample)
TWI605123B (zh) Cho表現系統
CN104718296B (zh) 包含嵌合巨细胞病毒启动子和增强子序列的表达载体
JP2019514358A5 (enExample)
JP2020509763A5 (enExample)
JPWO2017090685A1 (ja) Dnaポリメラーゼ変異体
US20230279583A1 (en) Randomized configuration targeted integration of nucleic acids
CN104975009B (zh) 一种新型的含mar核心片段的动物细胞表达载体
CN107893085B (zh) 一种可用于孤核受体活性调节剂筛选的双荧光素酶报告基因质粒及其构建与应用
JP2016512251A5 (enExample)
CA2611946C (en) Expression vector and methods of producing high levels of proteins
CA2538863A1 (en) Selection system containing non-antibiotic resistance selection marker
WO2021136227A1 (zh) Ch3 结构域改造诱导形成的异源二聚体及其制备方法和应用
Bertram et al. In vivo Activation of Tetracycline Rep ressor by Cre/lox-Mediated Gene Assembly
EP3966332A1 (en) Vectors and expression systems for producing recombinant proteins
CN103131701B (zh) 一种改进的人延长因子1α启动子
CN106632679B (zh) 兔抗人erk8多克隆抗体的制备方法
WO2025141778A1 (ja) 新規プロモーター
RU2021113649A (ru) Векторы для производства белков
CN102924577A (zh) 鸡高迁移率族蛋白b1抗原多肽和抗鸡高迁移率族蛋白b1单克隆抗体
RU2016152555A (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pBiPr-ABIgA2m1F16-ht ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИММУНОГЛОБУЛИНА А ИЗОТИПА IGA2m1
HK1206061B (en) Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences
HK1223973A1 (zh) 一株人工合成ii号染色体的酿酒酵母菌株
CN102533843A (zh) V5抗原表位融合性酵母表达载体及构建方法